Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$1,141.93	$83,491,746,043
	22,362,850	$1,141.93	$25,536,809,301
	17,233,668	$1,141.93	$19,679,642,500
	14,567,176	$1,141.93	$16,634,695,290
	9,033,726	$1,141.93	$10,315,882,732
	8,998,338	$1,141.93	$10,275,472,113
	8,322,140	$1,141.93	$9,503,301,331
	8,009,729	$1,141.93	$9,146,549,837
	7,619,135	$1,141.93	$8,700,518,831
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

Form SC 13D/A Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC Feb 21, 2024 04:13PM

Form SC 13D/A Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC Nov 17, 2023 08:28AM

Form SC 13D/A Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC Nov 14, 2023 08:53PM

Form SC 13D/A Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC May 8, 2023 05:01PM

Form SC 13D/A Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC May 3, 2023 06:03AM

May 2, 2023 09:35PM Form 4 Kinnate Biopharma Inc. For: Apr 28 Filed by: ORBIMED ADVISORS LLC
Feb 23, 2023 03:23PM Form SC 13D/A Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC
Feb 15, 2022 09:43PM Form 4 Kinnate Biopharma Inc. For: Feb 11 Filed by: ORBIMED ADVISORS LLC
Dec 11, 2020 04:40PM Form SC 13D Kinnate Biopharma Inc. Filed by: ORBIMED ADVISORS LLC
Dec 2, 2020 09:08PM Form 3 Kinnate Biopharma Inc. For: Dec 02 Filed by: ORBIMED ADVISORS LLC

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed